Tanini Annita
Corp. Controller & VP, Finance
Tanini Annita has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Aug 20, 2026.
On the most recent filing, Tanini Annita is listed as Corp. Controller & VP, Finance at Keros Therapeutics, Inc. Inside the rolling window, Tanini Annita reported no open-market purchases and 1 open-market sale totaling $13K in KROS.
Companies traded
Other insiders at KROS
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$13K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Tanini Annita made?
Tanini Annita has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company since 2026.
Which companies does Tanini Annita trade?
Tanini Annita has filed SEC Form 4 disclosures for 1 company, including KROS.
When was Tanini Annita's most recent SEC Form 4 filing?
Tanini Annita's most recent SEC Form 4 filing on Tracefour is dated Aug 20, 2026.
What is Tanini Annita's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Tanini Annita is listed as Corp. Controller & VP, Finance.
What is Tanini Annita's total buy and sell value in the current window?
Inside the rolling retention window, Tanini Annita bought $0 and sold $13K based on SEC Form 4 filings.
What was Tanini Annita's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 1,224 KROS shares on 2026-08-18, worth $13K, per SEC Form 4 filings.